Nanotechnology Applications to Biodefense Research

WSU CORE Repository

 

Nanotechnology Applications to Biodefense Research

Show simple item record

dc.contributor McRae, Rupert C.
dc.contributor Wooley, Dawn P.
dc.contributor.author Trefry, John
dc.coverage.temporal 2010 en_US
dc.date.accessioned 2011-06-17T17:07:28Z
dc.date.available 2011-06-17T17:07:28Z
dc.date.created 2010-04
dc.date.issued 2010-04
dc.identifier.other celebration_abstract10_trefry_j_2
dc.identifier.uri http://hdl.handle.net/2374.WSU/4763
dc.description.abstract

The bioterrorism attacks perpetrated after 9/11 have forced a change in biological research across the nation. The Department of Health and Human Services and The Department of Homeland Security have both called for immediate research on the development of countermeasures for biological weapons. Nanotechnology offers unique and far-reaching solutions to the needs of bio-threat elimination. Our research is based on the application of silver nanoparticles (AgNPs) as broad spectrum anti-viral as well as anti-bacterial agents. As viral countermeasures we have successfully demonstrated that AgNPs are capable of preventing the entry of a smallpox analog virus. To accomplish this task an FDA viral neutralization assay was modified to work during the viral entry time frame. The results show that AgNPs significantly prevent poxvirus entry at amounts as low as 63 Ilg/mL. Furthermore, AgNPs prevented the infection of the human immunodeficiency virus (HIV) bioengineered to express an entry factor that allows it to infect almost any cell in the human body, instead of its normal T-cell target. To determine AgNP effectiveness against HIV, a novel antiviral assay was created. Our novel assay shows AgNP inhibition of HIV as low as 2 Ilg/mL. The Wooley laboratory has also shown AgNPs have potent antibacterial properties against Staphylococcus aureus, Eschericia coli, and Yersinia pestis, the causative agent of plague. Using standard antimicrobial and drug development techniques, an effective antibacterial concentration was determined to be 17.5 Ilg/mL. AgNP toxicity testing has shown our standard 25 nm AgNPs to be nontoxic at concentrations as high as 1,000 Ilg/mL. The large gap between the effective antimicrobial and cytotoxic concentrations shows that AgNPs have the potential for a high therapeutic index. This suggests that AgNPs could be used as a broad-spectrum antimicrobial agent to protect the population from any sort of biological catastrophe, natural and man-made.

This presentation occurred at the Wright State University Campus-Wide Celebration of Research, Scholarship and Creative Activities on April 16, 2010

dc.language.iso en_US en_US
dc.publisher Wright State University en_US
dc.relation.ispartof Celebration of Research, Scholarship, and Creative Activities en_US
dc.rights.uri http://www.wright.edu/web/copyright.html
dc.subject Trefry, John en_US
dc.subject McRae, Rupert C. en_US
dc.subject Wooley, Dawn P. en_US
dc.subject Wright State University. Department of Neuroscience, Cell Biology and Physiology en_US
dc.title Nanotechnology Applications to Biodefense Research en_US
dc.type Presentation en_US
dc.permissions World
dc.publisher.digital Digital Services Department, Wright State University Libraries en_US
dc.date.digitized 2010-04
dc.publisher.OLinstitution Wright State University

Files in this item

Files Size Format View
celebration_abstract10_trefry_j_2.pdf 89.66Kb application/pdf Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search CORE


Advanced Search

Browse

My Account

About

Links